老年脓毒症相关性噬血细胞综合征的临床特征分析

doi:10.3969/j.issn.1003-9198.2023.03.016

摘要/Abstract

摘要： 目的分析老年脓毒症相关性噬血细胞性淋巴组织细胞增生症(HLH)病人的临床特征、实验室检查特点及转归,旨在早期发现,降低病死率。方法回顾性收集2013年6月至2022年3月南京市第一医院年龄≥65岁的32例老年脓毒症相关性HLH病人(老年组)的临床信息,并与同期收治的24例非老年脓毒症相关性HLH病人(非老年组)做比较,分析2组临床特点和病死率。结果与非老年组相比,老年组伴有高血压、脑血管疾病的比例更高,病人生存时间更短,差异均有统计学意义(P<0.05)。老年组28 d及90 d死亡率均高于非老年组(62.5%比25.0%,81.3%比45.8%,P均<0.05),BUN、血肌酐(SCr)、胱抑素C(CysC)及肌钙蛋白(TnT)水平高于非老年组(P<0.05);非老年组肝脾肿大发生率明显高于老年组(66.7%比25.0%,P<0.05);2组应用含激素的治疗方案的病死率差异无统计学意义(P>0.05)。结论老年脓毒症相关性HLH病死率更高,易并发心、肾功能损害,早发现、早治疗对降低病人病死率至关重要。

关键词: 噬血细胞综合征, 器官损害, 早期诊断, 预后

Abstract: Objective To analyze the clinical characteristics, laboratory test characteristics and prognosis of the elderly patients with sepsis-related hemophagocyic lymphohistiocytosis (HLH), and to provide evidence for early detection and reduction of mortality. Methods The clinical information of 32 elderly patients with sepsis-related HLH (aged group) and 24 non-elderly patients with sepsis-related HLH (non-aged group) from June 2013 to March 2022 in Nanjing First Hospital were retrospectively collected. The clinical characteristics and mortality of the two groups were analyzed and compared. Results The proportion of the patients with hypertension and cerebrovascular diseases was significantly higher and the survival time was shorter in the aged group than that in the non-aged group. The 28-day mortality rate and 90-day mortality rate in the aged group were higher than those in the non-aged group (62.5% vs 25.0%, 81.3% vs 45.8%, P<0.05), and there were significant differences in the levels of blood urine nitrogen (BUN), serum creatinine (SCr), Cystatin C (CysC) and Troponin T (TnT ) between the two groups (P<0.05). The aged group had a higher incidence rate of hepatosplenomegaly compared with the non-aged group (66.7% vs 25.0%, P<0.05). There was no significant difference in mortality due to different treatment regimens containing hormones between the two groups (P>0.05). Conclusions Sepsis-related HLH in the elderly patients has a higher mortality rate and is prone to causing heart and renal damage. Early detection and early treatment are crucial to reduce the mortality rate of the patients.

Key words: hemophagocytic syndrome, organ injury, early diagnosis, prognosis

中图分类号:

R 442.8

王念慈, 徐优, 柳叙, 刘颖, 刘汉. 老年脓毒症相关性噬血细胞综合征的临床特征分析[J]. 实用老年医学, 2023, 37(3): 278-281.

WANG Nian-ci, XU You, LIU Xu, LIU Ying, LIU Han. Analysis of clinical features of sepsis-associated hemophagocytic lymphohistiocytosis in the elderly[J]. Practical Geriatrics, 2023, 37(3): 278-281.

参考文献

[1] TROTTESTAM H, HORNE A, ARICO M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol[J]. Blood, 2011, 118(17):4577-4584.
[2] HENTER J I, HORNE A, ARICO M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2):124-131.
[3] LA ROSEE P, HORNE A, HINES M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019, 133(23):2465-2477.
[4] 王旖旎, 王昭. 成人噬血细胞性淋巴组织细胞增多症诊治建议解读[J]. 中华医学杂志, 2020, 100(24):1917-1920.
[5] 噬血细胞综合症中国专家联盟, 中华医学会儿科学分会血液学组.噬血细胞综合症诊治中国专家共识[J]. 中华医学杂志, 2018, 98(2):91-95.
[6] EVANS L, RHODES A, ALHAZZANI W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021, 49(11):e1063-e1143.
[7] JORDAN M B, ALLEN C E, GREENBERG J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)[J]. Pediatr Blood Cancer, 2019, 66(11):e27929.
[8] ESTEBAN Y M, JONG J L, TESHER M S. An overview of hemophagocytic lymphohistiocytosis[J]. Pediatr Ann, 2017, 46(8):e309-e313.
[9] HENTER J I, ELINDER G, SODER O, et al. Hypercytokinemia in familial hemophagocytic lymphohistio cytosis[J]. Blood, 1991, 78(11):2918-2922.
[10] 许汪斌, 钱冉, 代冬梅, 等. 成人感染相关性噬血细胞综合征32例临床分析[J]. 中华危重病急救医学, 2020, 32(7):797-802.
[11] 姜中兴, 马花, 孙慧, 等. 噬血细胞综合征临床特点与预后因素研究[J]. 重庆医学, 2017, 46(3):963-965.
[12] LACHMANN G, KNAAK C, VORDERWULBECKE G, et al. Hyperferritinemia in critically ill patients[J]. Crit Care Med, 2020, 48(4):459-465.
[13] RISMA K A, MARSH R A. Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis[J]. J Allergy Clin Immunol Pract, 2019, 7(3):824-832.
[14] LARROCHE C, MOUTHON L. Pathogenesis of hemophagocytic syndrome (HPS)[J]. Autoimmun Rev, 2004, 3(2): 69-75.

[1]	连芸, 蒋文, 朱方, 成语, 赵慧慧. 老年与年轻艾滋病相关淋巴瘤病人临床特点及预后分析[J]. 实用老年医学, 2024, 38(9): 920-925.
[2]	王新平, 谢柏梅, 卫国, 叶晓莉, 赵亚芸, 谭小田. 老年特发性间质性肺炎病人血清S100A9及sCD163表达水平及临床意义[J]. 实用老年医学, 2024, 38(8): 802-807.
[3]	薛冰艳, 徐瑞彤, 顾丹阳, 朱国琴. 81例老年胰腺神经内分泌肿瘤病人的临床病理特征与预后相关性分析[J]. 实用老年医学, 2024, 38(7): 718-721.
[4]	陈吐芬, 张波. 50例老年戊型肝炎临床特点与血清学特征分析[J]. 实用老年医学, 2024, 38(7): 722-726.
[5]	杨绍孔, 陈立文, 沈华, 张铮. 脓毒症心肌病诊断及预后标志物的研究进展[J]. 实用老年医学, 2024, 38(7): 748-752.
[6]	杜招娜, 姜文博, 牟俊宇, 俞成云, 夏伟. 经导管主动脉瓣置换术后新发持续完全性左束支传导阻滞的危险因素及短期预后分析[J]. 实用老年医学, 2024, 38(5): 500-437.
[7]	肖文, 胡秀, 李隽, 宋斌. 中性粒细胞/淋巴细胞比值与老年维持性血液透析病人预后的关系[J]. 实用老年医学, 2024, 38(4): 372-376.
[8]	胡芸, 汪曙红, 徐骥. 系统免疫炎症指数、白蛋白、甲胎蛋白与老年胃腺癌肝转移病人预后的相关性研究[J]. 实用老年医学, 2024, 38(4): 377-381.
[9]	王慧娟, 李霞. 主观认知下降转归为阿尔茨海默病的研究现状[J]. 实用老年医学, 2024, 38(4): 414-417.
[10]	彭泽通, 张尧, 刘斌. 贫血对老年社区获得性肺炎死亡的影响分析[J]. 实用老年医学, 2024, 38(3): 260-264.
[11]	陈璐, 姚俊英, 俞永贇, 范旻. MDT免疫营养支持治疗在老年颅脑手术病人中的应用效果[J]. 实用老年医学, 2024, 38(3): 278-282.
[12]	朱武刚, 翟晨彤, 刘德干, 徐文静. 外周血中性粒细胞与淋巴细胞比值对老年转移性食管癌免疫治疗预后的影响[J]. 实用老年医学, 2024, 38(2): 171-175.
[13]	李光耀, 叶碧华, 李小靓, 汤秦, 刘翠华. ApoB/ApoA1比值、甘油三酯-葡萄糖指数与老年创伤性脑损伤严重程度和预后的关系[J]. 实用老年医学, 2024, 38(10): 1049-1053.
[14]	张明, 陈曦, 刘跃洪, 谢德, 王志聪, 兰平文, 王光林. 红细胞体积分布宽度与老年髋部骨折病人预后的关系[J]. 实用老年医学, 2024, 38(1): 22-27.
[15]	孙洁, 查秀芳, 徐瑾, 赵君宁, 何伟, 张楠楠. 胃癌病人AHNAK表达与巨噬细胞浸润及预后的相关性[J]. 实用老年医学, 2024, 38(1): 49-53.